CompanyDrug

Polpharma Biologics’ Biosimilar Candidate PB016 Shows Comparable Profiles to Takeda’s Entyvio

CompanyDrug

Jiangsu Hengrui Receives NMPA Approval for Adjuvant Therapy Clinical Study of Adebrelimab in NSCLC

CompanyDrug

BioCity Biopharma Achieves Full Enrollment in Phase II Study of SC0062 for IgA Nephropathy

CompanyDrug

Livzon Pharmaceutical Gets CDE Green Light for JP-1366 Reflux Esophagitis Clinical Study

CompanyDrug

Hinova Pharmaceuticals’ HP537 Receives CDE Approval for Clinical Study in Hematologic Malignancies

CompanyDrug

Jiangsu Hengrui’s CD79b Targeting ADC SHR-A1912 Earns FDA Fast-Track Designation for R/R DLBCL

CompanyMedical Device

Rossum Robot’s Intelligent Surgical Robot for Trauma and Spinal Surgery Clears NMPA Approval

CompanyDrug

AstraZeneca’s Tagrisso Meets PFS Endpoint in Late-Stage NSCLC Trial and Expands FDA Approval

CompanyDrug

Pfizer’s Velsipity Approved by European Commission for Moderately to Severely Active Ulcerative Colitis

CompanyDrug

FDA Authorizes Biweekly Dosing for J&J’s Tecvayli in Multiple Myeloma Treatment

Company

AbbVie CEO Rick González to Retire, Succeeded by Robert A. Michael

CompanyDeals

Sinopharm Plans to Privatize China Traditional Medicine Holdings in a USD 2 Billion Deal